Adjuvant treatment for post-operative head and neck squamous cell carcinoma
Authors:
Open Access
- 19 November 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 45 (1) , 2-6
Abstract
One of the mainstays of treatment for locally advanced head and neck squamous cell carcinoma is surgery. However, for post-operative patients with high-risk factors for recurrence, surgery alone is insufficient and improving survival requires adjuvant treatment after surgery. Unlike with most other malignancies, the standard adjuvant treatment for post-operative head and neck cancer patients with high-risk factors for recurrence is radiotherapy concurrent with chemotherapy. This review article focuses on the history and future perspectives of adjuvant treatment for post-operative head and neck squamous cell carcinoma.Keywords
This publication has 24 references indexed in Scilit:
- The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavityRadiation Oncology, 2012
- Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective TrialClinical Oncology, 2011
- Long‐Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High‐Risk Head and Neck CancerThe Laryngoscope, 2008
- Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: A systematic review with meta‐analysisHead & Neck, 2006
- Risk‐group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapyCancer, 2005
- Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)Head & Neck, 2005
- Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal CarcinomaJNCI: Journal of the National Cancer Institute, 2005
- Combined postoperative radiotherapy and Weekly Cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Prognostic implications of perineural spread in squamous carcinomas of the head and neckThe Laryngoscope, 1986